tirzepatide obesity nejm A new study from compared (Mounjaro) to semaglutide (Wegovy) in people with (without type 2 diabetes). 🧬📉, Interested to see which one did better?, We’ve broken it down for VisualAbstract: Tirzepatide Superior to Semaglutide

The hepatic effects of Retatrutide are likely mediated by multiple mechanisms

To view or add a comment, sign in More Relevant Posts The semaglutide patent cliff is set to transform access to GLP-1 therapies in India and key emerging markets

Novo is locked in a close race with Eli Lilly to bring the first weight-loss pill to the market

Potential risks, contraindications, and monitoring requirements are reviewed during the consultation

(December 2009)

The study authors concluded, This cohort represents the largest study to date examining the [weight loss] effects of tirzepatide in women living with PCOS and overweight or obesity